Dementia Care Technology: HealthTech market to watch in 2025
- Lloyd Price
- 1 hour ago
- 10 min read
Exec Summary
The HealthTech market for dementia care in 2025 is poised for significant growth and innovation, driven by an aging global population, increasing dementia prevalence, and rapid advancements in technology. Below is an overview of key trends, opportunities, and areas to watch in this space:
Market Growth and Drivers
The global dementia care products market is expanding quickly, fueled by the rising number of people living with dementia—estimated at over 55 million in 2023 by the World Health Organization, with projections nearing 78 million by 2030. This surge is largely due to aging demographics, particularly in regions like North America, Europe, and Japan.
Market forecasts reflect this demand: the dementia care products market is expected to grow from approximately USD 25.56 billion in 2025 to USD 45.95 billion by 2034, at a compound annual growth rate (CAGR) of 6.73%, according to some industry analyses.
Meanwhile, the broader dementia treatment market, including pharmaceuticals and tech-enabled solutions, is projected to see a CAGR of around 8% from 2025 to 2030, starting from an estimated USD 18.03 billion in 2024.
Key drivers include heightened awareness of early diagnosis, the need for personalized care, and a push to reduce caregiver burden. Technological innovation is at the forefront, integrating artificial intelligence (AI), wearables, telemedicine, and smart home systems to enhance dementia care.
Key Dementia Technology Trends to Watch in 2025
AI-Powered Diagnostics and Monitoring
AI is revolutionising early detection and ongoing management of dementia. Tools like NeurEYE’s retina scan algorithm, which analyzes blood vessel patterns in the eye, are emerging as non-invasive ways to spot dementia years before symptoms escalate. In 2025, expect further refinement of AI models using vast datasets, like those from brain scans or wearable sensors, to predict cognitive decline with greater accuracy.
Example: NVIDIA’s advancements in portable brain imaging could make diagnostics more accessible, while startups like Mindset4Dementia are leveraging app-based AI to screen for early signs in home settings.
Wearables and Remote Monitoring
Wearable devices, such as smartwatches and skin-friendly patches, are increasingly used to track vital signs, sleep patterns, and activity levels in dementia patients. By 2025, these tools will likely integrate more sophisticated AI to detect anomalies—like irregular sleep or wandering behavior—alerting caregivers in real time.
The wearable healthcare devices market, projected to reach USD 70 billion by 2028, will play a significant role in dementia care, promoting independence while ensuring safety.
Smart Home Technologies
Smart home systems, including voice-activated assistants (e.g., Amazon’s Alexa), automated lighting, and sensors for motion or safety (e.g., CARU smart sensors), are transforming dementia care by enabling aging-in-place. In 2025, these solutions will become more tailored, learning patient routines and flagging deviations that might indicate cognitive decline or emergencies.
Japan, a leader in “Agetech,” is already testing robotics and smart systems to support its aging population, a trend likely to spread globally.
Telehealth and Virtual Care
Telemedicine platforms, bolstered by post-pandemic adoption, will expand in 2025 to offer remote consultations, cognitive therapy, and caregiver support for dementia patients. Companies like Amwell and Teladoc are setting the stage, with 63% of clinicians expecting most consultations to be virtual by 2032—a trend accelerating in dementia care.
This shift reduces the need for in-person visits, critical for patients with mobility issues.
Digital Therapeutics (DTx)
Digital therapeutics, such as apps for cognitive training or mood management, are gaining traction. In 2025, expect more FDA-approved DTx solutions tailored to dementia, offering scalable, non-invasive interventions. The DTx market, valued at USD 4.68 billion in 2024, is projected to grow at a CAGR of 16.61%, with dementia as a key focus area.
Ambient Assisted Living (AAL)
AAL technologies, combining sensors, AI, and connectivity, will enhance daily living for dementia patients. From bed occupancy sensors to fall detection systems, these tools reduce caregiver strain and improve patient safety. The AAL market is attracting investment as demand grows beyond traditional healthcare boundaries.
Opportunities in 2025
Personalisation: AI-driven tools that adapt to individual patient needs—such as customised cognitive exercises or medication reminders—will dominate, improving outcomes and quality of life.
Emerging Markets: Developing regions, where dementia prevalence is rising but healthcare infrastructure lags, present untapped potential for affordable, scalable tech solutions.
Partnerships: Collaborations between tech giants (e.g., Amazon, NVIDIA) and healthcare providers will accelerate innovation, as seen in Japan with partnerships like Nippontect and GE for early dementia detection platforms.
Dementia Tech Market Players to Watch
Tech Giants: NVIDIA (AI imaging), Amazon (health chatbots, Alexa), and IBM Watson (healthcare AI platforms)
Startups: Mindset4Dementia (AI screening apps), SafelyYou (fall detection), and Aikomi (non-drug therapy via sensory stimulation)
Pharma-Tech Hybrids: Companies like Eisai and Biogen, integrating tech with drug development for dementia
In 2025, the HealthTech market for dementia care will be a dynamic space to watch, blending cutting-edge technology with pressing healthcare needs. AI, wearables, and smart systems will lead the charge, offering hope for better management and early intervention. However, success will hinge on overcoming accessibility barriers and navigating ethical and regulatory landscapes. For investors, innovators, and caregivers, this sector promises both impact and opportunity as it reshapes how we support those living with dementia.
Nelson Advisors > HealthTech M&A
Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk
We work with our clients to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value and investment returns. Email lloyd@nelsonadvisors.co.uk
Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
We share our views on the latest Healthcare Technology mergers, acquisitions and partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
#HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #Cybersecurity #HealthcareAI #Partnerships #NHS #UK #Europe #USA #Canada
Nelson Advisors
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Contact Us
Meet Us
Digital Health Rewired > 18-19th March 2025
NHS ConfedExpo > 11-12th June 2025
HLTH Europe > 16-19th June 2025
HIMSS AI in Healthcare > 10-11th July 2025
Key Factors Making Dementia Care Technology a HealthTech Market to Watch in 2025:
Dementia care technology is indeed a significant area within the HealthTech market to watch in 2025.
Here's a breakdown of why, drawing from the provided search results:
Rising Prevalence of Dementia: With an aging global population, the number of individuals living with dementia is increasing significantly. This creates a growing demand for solutions that can support both patients and caregivers. For instance, the number of people living with dementia globally is expected to rise from an estimated 57.4 million in 2019 to 152.8 million by 2050.
Increased Awareness and Government Support: There's a growing awareness of dementia and the challenges it presents, leading to supportive government policies and initiatives aimed at improving diagnosis and care. In the UK, NHS England has a target to increase dementia diagnosis rates to 66.7% by March 2025.
Technological Advancements: Rapid advancements in areas like Artificial Intelligence (AI), wearable technology, the Internet of Things (IoT), and big data are being integrated into dementia care products and services, enhancing their effectiveness.
Focus on Early Detection and Personalised Care: AI and predictive analytics are being used for earlier and more accurate dementia risk prediction, enabling timely interventions. The market is also seeing a shift towards personalised and tailored care solutions that adapt to individual needs.
Remote Monitoring and Wearable Tech: Wearable devices like smartwatches and sensors are enabling real-time tracking of patients' movements, vital signs, and sleep patterns, allowing for timely interventions and reducing hospital admissions.
Integration of Health and Social Care Systems: There's a move towards unified digital platforms that allow seamless information flow between different healthcare providers, leading to more informed and coordinated care decisions. Interoperability of systems is recognised as crucial for effective dementia care.
Person-Centred Care Models: The focus is increasingly on technology that supports person-centered care, ensuring that the individual's needs and preferences are at the heart of their care plan.
Growth in Home-Based Care: With rising healthcare costs and a preference for familiar environments, there's a growing demand for technology that supports home-based dementia care, including monitoring systems and user-friendly devices.
Caregiver Support: Recognising the critical role of caregivers, there's a growing emphasis on technology and resources that support them, such as training programs and easy-to-use monitoring tools.
Market Growth Projections: The global dementia care products market is experiencing significant growth and is projected to reach substantial values in the coming years. For example, one analysis estimated the market size at USD 23.95 billion in 2024 and expects it to grow to USD 45.95 billion by 2034. Another report projects the global dementia care products market to reach USD 56.7 million by 2033.
Innovation and R&D: Continuous research and development are leading to innovative solutions like 24-hour monitoring bands, cognitive stimulation apps, and intelligent safety systems.
Public-Private Partnerships: Collaborations between government bodies and private companies are driving innovation and improving access to dementia care technologies.
Addressing Workforce Challenges: Technology is also being explored to optimise healthcare workforce management, which can indirectly benefit dementia care by ensuring adequate staffing and reducing administrative burdens.
10 Examples of Dementia Care Technologies
Wearable devices: Smartwatches and sensors for tracking location, activity, and vital signs.
GPS trackers: Devices to help locate individuals who may wander.
Home safety sensors: Motion sensors, door alarms, and fall detection systems.
Medication management tools: Automated pill dispensers and reminder apps.
Memory aids: Digital calendars, reminder devices, and voice-activated assistants.
Cognitive training apps and digital games: Tools to help keep the mind active.
Virtual reality (VR) and sensory devices: For cognitive stimulation and relaxation.
Communication aids: Devices and apps to facilitate communication.
Electronic Health Records: Facilitating seamless data sharing and better-informed care decisions.
AI-powered tools: For early diagnosis, personalised care plans, and predictive analytics.
The intersection of the increasing need for dementia care solutions and the rapid advancements in technology positions dementia care technology as a vital and dynamic segment within the HealthTech market to watch in 2025. The focus on improving the quality of life for individuals with dementia and supporting their caregivers will continue to drive innovation and growth in this area.
Future of Dementia Care in the next 2 years
The future of Dementia Care Technology in the HealthTech market over the next two years (2025-2027) looks incredibly promising and is poised for significant advancements.
Driven by the increasing global prevalence of dementia, greater awareness, and rapid technological innovations, this sector is expected to transform how we understand, diagnose, and manage the condition. Here's a look at some key trends and advancements anticipated:
Key Trends and Advancements Expected (2025-2027)
Enhanced AI and Predictive Analytics:
Earlier and More Accurate Diagnosis: AI algorithms will become increasingly sophisticated in analysing health records, genetic data (like APOE4), and even novel sources like retinal scans to predict dementia risk earlier, potentially years before clinical symptoms manifest.
Personalised Interventions: AI will be crucial in tailoring care plans based on individual patient profiles, disease progression, and response to interventions. This includes personalized cognitive training, medication management, and lifestyle recommendations.
Behavioural Pattern Analysis: Machine learning will be used to analyze data from wearable devices and smart home sensors to detect subtle changes in behavior, sleep patterns, and daily routines that could indicate disease progression or emerging issues like increased risk of falls or wandering.
Smarter Wearable and Sensor Technologies:
Advanced Monitoring: Wearables will go beyond basic activity tracking to include continuous monitoring of vital signs (heart rate, sleep patterns), and potentially even early indicators of cognitive decline through subtle changes in gait or speech patterns.
Discreet and User-Friendly Designs: Focus will be on developing less obtrusive and more user-friendly devices with longer battery life to encourage consistent wear, especially for individuals with cognitive impairments who may forget to charge or put them on.
Integration with Smart Homes: Seamless integration of wearables and sensors with smart home technologies will create supportive environments that can automatically adjust lighting, temperature, and provide reminders, enhancing safety and independence.
Focus on Communication and Social Engagement:
AI-Powered Communication Aids: Development of more sophisticated AI-powered tools to assist with communication difficulties, such as word-finding assistance, real-time translation, and visual communication aids.
Virtual and Augmented Reality (VR/AR): Increased use of VR and AR for cognitive stimulation, reminiscence therapy, and creating immersive experiences that can enhance well-being and reduce feelings of isolation.
Platforms for Remote Social Connection: Expansion of user-friendly digital platforms designed specifically for people with dementia and their families to facilitate remote communication, share memories, and participate in virtual social activities.
Advancements in Drug Therapies and Biomarkers:
Disease-Modifying Drugs: The next two years will likely see further developments and potential approvals of new disease-modifying drugs (like Remternetug, Butanetap, Semaglutide) that target underlying Alzheimer's pathology, offering hope for slowing disease progression, particularly in early stages.
Blood-Based Biomarkers: The development and wider adoption of reliable and less invasive blood tests for early detection of amyloid and tau proteins, as well as other dementia-related biomarkers, will revolutionize diagnosis and enable earlier intervention.
Combination Therapies: Research will likely focus on combination therapies that target multiple aspects of the disease, potentially combining pharmacological and non-pharmacological interventions for synergistic effects.
Integration of Care Ecosystems:
Interoperable Digital Platforms: A push towards unified digital platforms that seamlessly integrate data from various healthcare providers, social care services, and home monitoring systems to provide a holistic view of the patient's condition and needs.
Enhanced Caregiver Support Technologies: Development of more comprehensive digital tools and resources to support caregivers, including personalised training programs, stress management tools, and platforms for connecting with support networks.
Personalised and Adaptive Assistive Technologies:
Customisable Solutions: A move towards assistive technologies that can be customised and adapted by users and caregivers to meet evolving needs and preferences, promoting greater independence.
Intelligent Robotic Assistants: While still in early stages, the potential for more sophisticated robotic devices to assist with daily tasks, medication reminders, and even provide companionship may see further exploration and development.
Challenges and Considerations:
Data Privacy and Security: Ensuring the ethical and secure handling of sensitive health data collected through various technologies will be paramount.
Accessibility and Inclusivity: Technologies must be designed to be user-friendly and accessible to individuals with varying levels of cognitive impairment and technological literacy, as well as across different socioeconomic backgrounds.
Integration into Existing Healthcare Systems: Successful adoption will require seamless integration of new technologies into existing clinical workflows and healthcare infrastructure.
Cost and Reimbursement: The cost-effectiveness of new technologies and the development of appropriate reimbursement models will be crucial for widespread adoption.
User Acceptance and Training: Adequate training and support for both patients and caregivers will be essential for the successful implementation and long-term use of dementia care technologies.
The next two years promise exciting advancements in dementia care technology. The focus will be on leveraging AI, sophisticated sensors, and integrated platforms to achieve earlier diagnosis, personalized care, enhanced safety and independence for individuals living with dementia, and improved support for their caregivers. While challenges remain, the momentum in research and innovation suggests a transformative period ahead in this critical area of HealthTech.
Nelson Advisors > HealthTech M&A
Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk
We work with our clients to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value and investment returns. Email lloyd@nelsonadvisors.co.uk
Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
We share our views on the latest Healthcare Technology mergers, acquisitions and partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
#HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #Cybersecurity #HealthcareAI #Partnerships #NHS #UK #Europe #USA #Canada
Nelson Advisors
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Contact Us
Meet Us
Digital Health Rewired > 18-19th March 2025
NHS ConfedExpo > 11-12th June 2025
HLTH Europe > 16-19th June 2025
HIMSS AI in Healthcare > 10-11th July 2025
